Prevention of infection-related cancers in the WHO Western Pacific Region (Q26777318)

1

0 references

Aesun Shin

2

0 references

Hyeongtaek Woo

3

0 references

Kimberley Fox

4

0 references

Nick Walsh

5

0 references

Ying-Ru Lo

6

0 references

Eric Wiesen

7

0 references

Cherian Varghese

Japanese Journal of Clinical Oncology

8

0 references

language of work or name

English

0 references

publication date

January 2016

0 references

published in

0 references

volume

46

0 references

issue

1

0 references

page(s)

13-22

0 references

cites work

Global burden of cancers attributable to infections in 2008: a review and synthetic analysis

1 reference

https://api.crossref.org/works/10.1093%2FJJCO%2FHYV092

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJJCO%2FHYV092

A review of human carcinogens--Part B: biological agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJJCO%2FHYV092

Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJJCO%2FHYV092

The risk of perinatal hepatitis B virus transmission: hepatitis B e antigen (HBeAg) prevalence estimates for all world regions

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJJCO%2FHYV092

Global epidemiology and genotype distribution of the hepatitis C virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJJCO%2FHYV092

Global epidemiology of hepatitis B and hepatitis C in people who inject drugs: results of systematic reviews

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJJCO%2FHYV092

Epidemiology of hepatitis C virus infection and risk factor analysis in the Hebei Province, China

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJJCO%2FHYV092

Hepatocellular carcinoma in the Asia pacific region

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJJCO%2FHYV092

Estimation of cancer cases and deaths attributable to infection in China

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJJCO%2FHYV092

Hepatitis B and C virus infection and hepatocellular carcinoma in China: a review of epidemiology and control measures

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJJCO%2FHYV092

Population attributable fraction of infection-related cancers in Korea

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJJCO%2FHYV092

The causes of cancer in France

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJJCO%2FHYV092

11. Cancers attributable to infection in the UK in 2010.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJJCO%2FHYV092

The global health burden of infection-associated cancers in the year 2002

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJJCO%2FHYV092

Hepatitis B control by 2012 in the WHO Western Pacific Region: rationale and implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJJCO%2FHYV092

Hepatitis B control in the World Health Organization's Western Pacific Region: targets, strategies, status

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJJCO%2FHYV092

Global epidemiology of hepatitis B virus infection: new estimates of age-specific HBsAg seroprevalence and endemicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJJCO%2FHYV092

Human papillomavirus types in invasive cervical cancer worldwide: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJJCO%2FHYV092

Epidemiology of Helicobacter pylori infection and gastric cancer in Asia

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJJCO%2FHYV092

Helicobacter pylori Eradication on the Prevention of Metachronous Lesions after Endoscopic Resection of Gastric Neoplasm: A Meta-Analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJJCO%2FHYV092

Epidemiological serosurvey of hepatitis B in China--declining HBV prevalence due to hepatitis B vaccination.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJJCO%2FHYV092

Evaluation of the impact of hepatitis B vaccination among children born during 1992-2005 in China

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJJCO%2FHYV092

Sex- and age-specific carriers of hepatitis B and C viruses in Japan estimated by the prevalence in the 3,485,648 first-time blood donors during 1995-2000.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJJCO%2FHYV092

Chronic hepatitis B prevalence among children and mothers: results from a nationwide, population-based survey in Lao People's Democratic Republic

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJJCO%2FHYV092

Impact of the universal hepatitis B immunization program in Mongolia: achievements and challenges.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJJCO%2FHYV092

Age-specific prevalence of hepatitis B surface antigenaemia in hospitalized children at Port Moresby, Papua New Guinea (a cross-sectional study with implications for the Hepatitis B Control Programme).

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJJCO%2FHYV092

HTLV-I, HIV-I, and hepatitis B and C viruses in Western Province, Papua New Guinea: a serological survey.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJJCO%2FHYV092

Recent trends in hepatitis B virus infection in the general Korean population

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJJCO%2FHYV092

Seroepidemiology of hepatitis B virus infection among adults in Singapore: a 12-year review

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJJCO%2FHYV092

Seroprevalence of hepatitis B virus infection among children and adolescents in Singapore, 2008-2010.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJJCO%2FHYV092

A reduction in chronic hepatitis B virus infection prevalence among children in Vietnam demonstrates the importance of vaccination

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJJCO%2FHYV092

Effect of a hepatitis B vaccination program on the prevalence of hepatitis B virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJJCO%2FHYV092

Prevalence of hepatitis B virus infection in the Austral archipelago, French Polynesia: identification of transmission patterns for the formulation of immunization strategies

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJJCO%2FHYV092

Molecular epidemiological study of hepatitis B virus infection in two different ethnic populations from the Solomon Islands

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJJCO%2FHYV092

Improved immunization practices reduce childhood hepatitis B infection in Tonga.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJJCO%2FHYV092

A systematic review of hepatitis C virus epidemiology in Asia, Australia and Egypt

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJJCO%2FHYV092

Update on epidemiology of hepatitis B and C in China

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJJCO%2FHYV092

Detection of HCV RNA in subjects with antibody to hepatitis C virus among the general population of Fukuoka, Japan

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJJCO%2FHYV092

Prevalence and genotype distribution of hepatitis C virus among apparently healthy individuals in Mongolia: a population-based nationwide study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJJCO%2FHYV092

Prevalence and determinants of Helicobacter pylori sero-positivity in the Australian adult community.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJJCO%2FHYV092

Prevalence and risk factors for Helicobacter pylori infection in Chinese populations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJJCO%2FHYV092

Prevalence and risk factors of Helicobacter pylori infection in Korea: nationwide multicenter study over 13 years

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJJCO%2FHYV092

Human papillomavirus infection in Ulaanbaatar, Mongolia: a population-based study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJJCO%2FHYV092

Prevalence and risk factors of Human Papillomavirus (HPV) infection in southern Chinese women - a population-based study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJJCO%2FHYV092

Human papillomavirus infections among Japanese women: age-related prevalence and type-specific risk for cervical cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJJCO%2FHYV092

The global epidemiology of clonorchiasis and its relation with cholangiocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJJCO%2FHYV092

The impact of a new universal infant and school-based adolescent hepatitis B vaccination program in Australia

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJJCO%2FHYV092

7 January 2021

Hepatitis B vaccines: WHO position paper--recommendations

1 reference

https://api.crossref.org/works/10.1093%2FJJCO%2FHYV092

7 January 2021

Hepatitis B virus infection

1 reference

https://api.crossref.org/works/10.1093%2FJJCO%2FHYV092

7 January 2021

The effectiveness of the infant hepatitis B immunisation program in Fiji, Kiribati, Tonga and Vanuatu

1 reference

https://api.crossref.org/works/10.1093%2FJJCO%2FHYV092

7 January 2021

10 year assessment of infant hepatitis B vaccination program, in the Loyalty Islands (New Caledonia)

1 reference

https://api.crossref.org/works/10.1093%2FJJCO%2FHYV092

7 January 2021

Attributable causes of cancer in Japan in 2005--systematic assessment to estimate current burden of cancer attributable to known preventable risk factors in Japan

1 reference

https://api.crossref.org/works/10.1093%2FJJCO%2FHYV092

7 January 2021

Impact of routine hepatitis B immunization on the prevalence of chronic hepatitis B virus infection in the marshall islands and the federated States of micronesia

1 reference

https://api.crossref.org/works/10.1093%2FJJCO%2FHYV092

7 January 2021

Lung cancer incidence and mortality in China, 2010

1 reference

https://api.crossref.org/works/10.1093%2FJJCO%2FHYV092

7 January 2021

Cervical cancer: particularities in HIV patients

1 reference

https://api.crossref.org/works/10.1093%2FJJCO%2FHYV092

7 January 2021

Hepatitis B infection among adults in the philippines: A national seroprevalence study

1 reference

https://api.crossref.org/works/10.1093%2FJJCO%2FHYV092

7 January 2021

The Occurrence of Hepatitis B Antigen and Antibody in some Population Groups in the Southwest Pacific Region *

1 reference

https://api.crossref.org/works/10.1093%2FJJCO%2FHYV092

7 January 2021

Studies on hepatitis B surface antigen and antibody in Nauru. II. Distribution amongst Gilbert and Ellice (Tuvalu) islanders

1 reference

https://api.crossref.org/works/10.1093%2FJJCO%2FHYV092

7 January 2021

Hepatitis B infection in rural Vietnam and the implications for a national program of infant immunization.

1 reference

https://api.crossref.org/works/10.1093%2FJJCO%2FHYV092

7 January 2021